QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

FDA gains power to destroy counterfeit tobacco at the border

H.R. 5986 — END Illicit Chinese Tobacco Act · Filed by Beth Van Duyne (R-TX) · 1 cosponsor · Introduced Nov 7, 2025 · Referred to committee

85%
Transparency
Typical bill: 82%
5/100
Hidden-provision risk
Typical bill: 15/100
Border Protection / Public Health

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill authorizes the Secretary of Health and Human Services to destroy tobacco products that are adulterated, misbranded, or counterfeit when they arrive at U.S. ports for import. It amends the Federal Food, Drug, and Cosmetic Act to treat counterfeit and adulterated tobacco products the same way the law already treats counterfeit and adulterated drugs and devices — allowing them to be seized and destroyed rather than admitted into commerce.

Why we flagged it

The bill's operative mechanism is straightforward: it extends existing import-seizure authority (already applied to drugs and devices) to tobacco products. This is a routine public-health measure aimed at blocking counterfeit and adulterated goods at the border.

What the text implies

  • The bill does not define what constitutes 'adulterated' or 'misbranded' tobacco — those definitions live in existing FDCA § 900 and related tobacco-specific statutes (Family Smoking Prevention and Tobacco Control Act). The Secretary's destruction authority will be bounded by those existing definitions, which may or may not cover all counterfeit products depending on how 'counterfeit tobacco produc
  • The bill applies retroactively to the date of enactment, meaning any tobacco products in the import queue on that date become subject to destruction authority immediately — no grandfather period.

The full analysis lists 3 implications of this text.

Who it affects

Consumers gain protection against counterfeit and adulterated tobacco products entering the U.S. market, reducing health risks from unregulated or contaminated products.

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record